Which Application Segment Driving The Demand Of Particle Therapy market?

By Author: Johnny
Total Articles: 114
Comment this article

Particle Therapy Industry Overview

Global particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

Particle Therapy Market

Market growth is driven by factors such as growing adoption of particle therapy in clinical trials and the increasing number of particle therapy centers worldwide. Emerging markets are China India, Brazil, and South Africa are showing lucrative growth opportunities to market.

Covid-19 Impact on Economic Scenario in Particle Therapy Market

Globally, the outbreak of COVID-19 has impacted every aspect of the medical device industry, including particle therapy devices. From region to region, there is considerable variation in the management of particle therapy procedures during the COVID-19 pandemic. The particle therapy market is expected to be impacted due to the temporary postponement of various elective surgeries as governments and authorities seek to ensure the availability of resources ...
... for COVID-19 patients.

Particle Therapy Market Segmentation

Pediatric cancer defined for the largest share in the particle therapy market by cancer type

Based on cancer type, the particle therapy market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment is holds the largest share of 24.8% of the particle therapy market in 2021 with CAGR of 10.4% during the forecast period.

Products such as cyclotron accounted for the largest share in the particle therapy market by product type

Based on products & services, the particle therapy market is segmented into products and services. In 2021, products are estimated to account for the largest share of 78.6% of the particle therapy market.

Based on system, multi-room systems holds the largest share in the particle therapy

Based on the system, the particle therapy market is segmented into single-room and multi-room particle therapy systems. The multi-room systems segment is expected to account for the largest share (67.8%) of the particle therapy market.

Particle Therapy Regional Outlook

North America
Europe
Asia pacific
Latin america
Middle east & Africa
Key Companies Profile & Market Share Insights

Prominent players in the particle therapy market include Varian Medical Systems, Inc. (US), IBA Worldwide (EU), Mevion Medical Systems (US), Provision Healthcare, LLC (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), Protom International, Inc. (US), Advanced Oncotherapy PLC. (EU), and Danfysik A/S (Denmark)

IBA is one of the leading players in the particle therapy market. Its Proton Therapy segment offers Proteus PLUS, a treatment room solution, and Proteus ONE, a single-room cancer treatment solution.

Order a free sample PDF of the Particle Therapy Market Intelligence Study, published by MarketsandMarkets.